T1	intervention 26 56	axillary reverse mapping (ARM)
T3	total-participants 1081 1084	280
T5	control 1245 1258	standard ALND
T12	location 2026 2037	Netherlands
T2	eligibility 1085 1204	patients diagnosed with SLN biopsy-proven metastasis of invasive breast cancer with an indication for a completion ALND
T6	outcome-Measure 1373 1420	presence of axillary surgery-related lymphedema
T4	outcome-Measure 1541 1545	pain
T7	outcome-Measure 1547 1558	paresthesia
T8	outcome-Measure 1560 1568	numbness
T9	outcome-Measure 1574 1599	loss of shoulder mobility
T10	outcome-Measure 1601 1616	quality of life
T11	outcome-Measure 1622 1646	axillary recurrence risk
